clinical trials

Conatus Pharma to explore options as liver disease drug fails trial
Conatus Pharma to explore options as liver disease drug fails trial
Yahoo/Reuters
Conatus Pharmaceuticals
clinical trials
NASH
emricasan
Novartis
Flag link:
Better than Ambien? Minerva soars on PhIIb update on seltorexant for insomnia
Better than Ambien? Minerva soars on PhIIb update on seltorexant for insomnia
Endpoints
Minerva
insomnia
clinical trials
seltorexant
Flag link:
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Bristol-Myers star Opdivo fails survival test in a matchup with Nexavar aimed at shaking up the big HCC market
Endpoints
Bristol-Myers Squibb
Opdivo
Bayer
Nexavar
liver cancer
clinical trials
Flag link:
AbbVie gets a green light to resume recruiting patients for one myeloma study — but Venclexta remains under a cloud
AbbVie gets a green light to resume recruiting patients for one myeloma study — but Venclexta remains under a cloud
Endpoints
AbbVie
Venclexta
Multiple Myeloma
FDA
clinical trials
Flag link:
Bayer begins phase 3 trial testing aflibercept in infant blindness
Bayer begins phase 3 trial testing aflibercept in infant blindness
Pharmaforum
Bayer
clinical trials
infant blindness
Aflibercept
retinopathy of prematurity
Flag link:
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Roche/Exelixis' Cotellic fizzles in pivotal melanoma study
Endpoints
Roche
Exelixis
Cotellic
Tecentriq
clinical trials
advanced melanoma
Flag link:
Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate
Horizon Therapeutics initiates MIRROR trial evaluating KRYSTEXXA in combination with methotrexate
Pharmaceutical Business Review
Horizon Therapeutics
clinical trials
uncontrolled gout
gout
Krystexxa
Flag link:
Survey Says: Fragmented Processes and System Silos are Hurting Clinical Trials
Survey Says: Fragmented Processes and System Silos are Hurting Clinical Trials
Medical Devices and Diagnostics Industry
system silos
devices
clinical trials
Flag link:
Bayer’s regorafenib kicks off brain cancer platform trial
Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Bayer
brain cancer
clinical trials
GBM
regorafenib
Flag link:
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Ironwood, Allergan adds a slate of PhIIIb data to its Linzess pitch for physicians, patients
Endpoints
Ironwood Pharmaceuticals
Allergan
Linzess
clinical trials
IBS-C
Flag link:
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
JNJ
Janssen
Tremfya
clinical trials
psoriatic arthritis
Flag link:
Here's Why Unity Biotechnology Dropped as Much as 20.4% Today
Here's Why Unity Biotechnology Dropped as Much as 20.4% Today
Motley Fool
Unity Biotechnology
clinical trials
UBX0101
osteoarthritis
Flag link:
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody
Boehringer, OSE doses first patient in phase 1 trial of SIRPα antagonist monoclonal antibody
Pharmaceutical Business Review
Boehringer Ingelheim
OSE Immuotherapeutics
clinical trials
BI 765063
solid tumors
Flag link:
RWE and the Future of Drug Development
RWE and the Future of Drug Development
Xtalks
drug development
clinical trials
RWE
Flag link:
VBI hepatitis B vaccine meets main goals in late-stage trial
VBI hepatitis B vaccine meets main goals in late-stage trial
Yahoo/Reuters
VBI Vaccines
hepatitis B
vaccines
GSK
Engerix-B
Sci-B-Vac
clinical trials
Flag link:
Enanta's lung infection therapy succeeds in mid-stage trial
Enanta's lung infection therapy succeeds in mid-stage trial
Reuters
Enanta Pharmaceuticals
RSV
clinical trials
EDP-938
Flag link:
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
Flag link:
Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint
Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint
BioSpace
Chi-Med
neuroendocrine tumors
clinical trials
surufatinib
Flag link:
Study Finds Hundreds of Medical Procedures To Be Ineffective
Study Finds Hundreds of Medical Procedures To Be Ineffective
Forbes
clinical trials
effectiveness
devices
Flag link:
Here's Why Savara Pharmaceuticals Collapsed Today
Here's Why Savara Pharmaceuticals Collapsed Today
Motley Fool
Savara Pharmaceuticals
molgradex
clinical trials
aPAP
Flag link:

Pages